SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bhawna Sirohi, Ashish Singh, Shaheenah Dawood, Shailesh V. Shrikhande, Advances in Chemotherapy for Pancreatic Cancer, Indian Journal of Surgical Oncology, 2015, 6, 1, 47

    CrossRef

  2. 2
    Ali Mokdad, Michael A. Choti, Adam C. Yopp, Conversion Chemotherapy for Unresectable Colorectal Liver Metastases: Are We Making a Difference?, Current Colorectal Cancer Reports, 2015, 11, 4, 160

    CrossRef

  3. 3
    Eran Sadot, Alexandre Doussot, Eileen M. O’Reilly, Maeve A. Lowery, Karyn A. Goodman, Richard Kinh Gian Do, Laura H. Tang, Mithat Gönen, Michael I. D’Angelica, Ronald P. DeMatteo, T. Peter Kingham, William R. Jarnagin, Peter J. Allen, FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma, Annals of Surgical Oncology, 2015,

    CrossRef

  4. 4
    L.R. Jaidev, Uma Maheswari Krishnan, Swaminathan Sethuraman, Gemcitabine loaded biodegradable PLGA nanospheres for in vitro pancreatic cancer therapy, Materials Science and Engineering: C, 2015, 47, 40

    CrossRef

  5. 5
    Pablo E. Serrano, Sean P. Cleary, Neesha Dhani, Peter T. W. Kim, Paul D. Greig, Kenneth Leung, Carol-Anne Moulton, Steven Gallinger, Alice C. Wei, Improved Long-Term Outcomes After Resection of Pancreatic Adenocarcinoma: A Comparison Between Two Time Periods, Annals of Surgical Oncology, 2015, 22, 4, 1160

    CrossRef

  6. 6
    Ronica H. Nanda, Bassel El-Rayes, Shishir K. Maithel, Jerome Landry, Neoadjuvant modified FOLFIRINOX and chemoradiation therapy for locally advanced pancreatic cancer improves resectability, Journal of Surgical Oncology, 2015, 111, 8
  7. 7
    Megan Winner, Stephanie L. Goff, John A. Chabot, Neoadjuvant therapy for Non-metastatic Pancreatic Ductal Adenocarcinoma, Seminars in Oncology, 2015, 42, 1, 86

    CrossRef

  8. 8
    Andrew Yang, Eileen M O’Reilly, Novel directions in neoadjuvant therapy for pancreas adenocarcinoma, Expert Review of Gastroenterology & Hepatology, 2015, 9, 5, 585

    CrossRef

  9. 9
    Ryosuke Amano, Kenjiro Kimura, Bunzo Nakata, Sadaaki Yamazoe, Hisashi Motomura, Akira Yamamoto, Sayaka Tanaka, Kosei Hirakawa, Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer, Surgery, 2015, 158, 1, 191

    CrossRef

  10. 10
    Anne Elias, Nikolaos A. Chatzizacharias, Athanasios Xanthis, Pippa Corrie, Susan Davies, Rebecca J. Brais, Neville V. Jamieson, Raaj K. Praseedom, Emmanuel Huguet, Simon J. F. Harper, Asif Jah, Salvage Pancreaticoduodenectomy After Complete Response to Chemoradiotherapy for a Previously Unresectable Pancreatic Adenosquamous Carcinoma, Medicine, 2015, 94, 6, e499

    CrossRef

  11. 11
    Aaron J. Franke, Lauren M. Rosati, Timothy M. Pawlik, Rachit Kumar, Joseph M. Herman, The Role of Radiation Therapy in Pancreatic Ductal Adenocarcinoma in the Neoadjuvant and Adjuvant Settings, Seminars in Oncology, 2015, 42, 1, 144

    CrossRef

  12. 12
    Kensuke Kubota, Takamitsu Sato, Seitaro Watanabe, Kunihiro Hosono, Noritoshi Kobayashi, Ryutaro Mori, Koichi Taniguchi, Ryusei Matsuyama, Itaru Endo, Atsushi Nakajima, Covered self-expandable metal stent deployment promises safe neoadjuvant chemoradiation therapy in patients with borderline resectable pancreatic head cancer, Digestive Endoscopy, 2014, 26, 1
  13. 13
    Yasuhiro Kodera, Daisuke Kobayashi, Chie Tanaka, Michitaka Fujiwara, Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?, Surgery Today, 2014,

    CrossRef

  14. 14
    Abhishek Mitra, Bhawna Sirohi, Shailesh V. Shrikhande, Neoadjuvant therapy in pancreatic cancer, Current Medicine Research and Practice, 2014, 4, 2, 56

    CrossRef

  15. 15
    F. Lordick, M. Knödler, U. Hacker, M. Bartels, Neoadjuvante Chemotherapie oder primäre Chirurgie bei kolorektalen Lebermetastasen, Der Chirurg, 2014, 85, 1, 11

    CrossRef

  16. 16
    Ana Sebio, Sebastian Stintzing, Stefan Stremitzer, Wu Zhang, Heinz-Josef Lenz, Panitumumab: leading to better overall survival in metastatic colorectal cancer?, Expert Opinion on Biological Therapy, 2014, 14, 4, 535

    CrossRef

  17. 17
    Nestor F. Esnaola, Uzair B. Chaudhary, Paul O'Brien, Elizabeth Garrett-Mayer, E. Ramsay Camp, Melanie B. Thomas, David J. Cole, Alberto J. Montero, Brenda J. Hoffman, Joseph Romagnuolo, Kelly P. Orwat, David T. Marshall, Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed by Selective Capecitabine-Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer, International Journal of Radiation Oncology*Biology*Physics, 2014, 88, 4, 837

    CrossRef

  18. 18
    Daniel M. Halperin, Gauri R. Varadhachary, Resectable, Borderline Resectable, and Locally Advanced Pancreatic Cancer: What Does It Matter?, Current Oncology Reports, 2014, 16, 2

    CrossRef

  19. 19
    Matthew H. G. Katz, Robert Marsh, Joseph M. Herman, Qian Shi, Eric Collison, Alan P. Venook, Hedy L. Kindler, Steven R. Alberts, Philip Philip, Andrew M. Lowy, Peter W. T. Pisters, Mitchell C. Posner, Jordan D. Berlin, Syed A. Ahmad, Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design, Annals of Surgical Oncology, 2013, 20, 8, 2787

    CrossRef

  20. 20
    Chang Moo Kang, Ho Kyoung Hwang, Sung Hoon Choi, Woo Jung Lee, Controversial issues of neoadjuvant treatment in borderline resectable pancreatic cancer, Surgical Oncology, 2013, 22, 2, 123

    CrossRef

  21. 21
    Somnath Mukherjee, Christopher N Hurt, John Bridgewater, Stephen Falk, Sebastian Cummins, Harpreet Wasan, Tom Crosby, Catherine Jephcott, Rajarshi Roy, Ganesh Radhakrishna, Alec McDonald, Ruby Ray, George Joseph, John Staffurth, Ross A Abrams, Gareth Griffiths, Tim Maughan, Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial, The Lancet Oncology, 2013, 14, 4, 317

    CrossRef

  22. 22
    Brian A. Boone, Jennifer Steve, Alyssa M. Krasinskas, Amer H. Zureikat, Barry C. Lembersky, Michael K. Gibson, Ronald G. Stoller, Herbert J. Zeh, Nathan Bahary, Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer, Journal of Surgical Oncology, 2013, 108, 4
  23. 23
    Amanda B. Cooper, Ching-Wei D. Tzeng, Matthew H. G. Katz, Treatment of Borderline Resectable Pancreatic Cancer, Current Treatment Options in Oncology, 2013, 14, 3, 293

    CrossRef